Guido Kroemer is a professor at the University of Paris Descartes specializing in immunology, cancer biology, aging, and autophagy. His research investigates mechanisms of regulated cell death, including apoptosis, ferroptosis, and immunogenic cell death. His publications also explore cancer immunotherapy, gut microbiota interventions in oncology, and therapeutic targets in metabolic and age-related diseases.
Two days of fasting causes about a 20% loss of body weight in mice, whereas four days of fasting in humans causes only a 1% to 2% weight loss.
"The 2 days that you have been alluding to cause a 20% weight loss in mice that are at this time point at the verge of death... In 4 days, a human being only loses 1 to 2% of his or her weight." (said at 0:18:04)
The speaker's comparison illustrates the profound difference in mass-specific metabolic rate between rodents and humans during fasting, but underestimates the typical short-term weight loss in humans. In mice, a 48-hour total fast produces severe physiological stress and substantial weight loss (often approaching 15% to 20% of total body weight). However, in humans, a complete four-day fast typically results in a 3% to 6% reduction in body weight (approximately 2.5 to 4.5 kg in an average adult), driven primarily by acute glycogen depletion and obligate fluid loss alongside tissue catabolism, rather than merely 1% to 2%.
Approximately one-third of the spermidine in the human body is produced by the intestinal microbiota.
"it is produced by our microbiota. So, 1/3 of the spermidine in our bodies is probably produced in the intestine." (said at 0:55:17)
The body's pool of polyamines, including spermidine, is derived from three primary pathways: endogenous (de novo cellular) synthesis, dietary intake, and production by the gut microbiota. Attributing roughly one-third of the body's supply to intestinal microbial synthesis represents a common conceptual approximation among these three sources, though exact individual contributions vary and are challenging to quantify precisely in humans.
Heavy coffee consumption is epidemiologically associated with a reduced risk of cardiovascular and neurodegenerative diseases.
"Well, coffee use has been linked to major uh health-promoting effects. So, uh most cardiovascular and neurodegenerative diseases are actually reduced in heavy coffee drinkers as an independent link between lifestyle and pathology." (said at 1:02:14)
Epidemiological studies and umbrella reviews consistently show that coffee consumption is associated with a lower risk of cardiovascular disease (CVD), cardiovascular mortality, and certain neurodegenerative diseases (particularly Parkinson's disease). However, the dose-response relationship differs by outcome: for cardiovascular disease, the relationship is non-linear (U-shaped), with the largest risk reductions observed at moderate intake (3 to 5 cups per day) and attenuated risk reduction among heavy drinkers. In contrast, inverse associations for neurodegenerative outcomes like Parkinson's disease show a more linear, dose-dependent decrease in risk. Additionally, because the evidence is observational, these associations reflect epidemiological correlations rather than established causation.
- context: Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a… (Circulation 2014) · cited 574x in the literature
"A nonlinear association between coffee consumption and CVD risk was observed in this meta-analysis. Moderate coffee consumption was inversely significantly associated with CVD risk, with the lowest CVD risk at 3 to 5 cups per day, and heavy coffee consumption was not associated with elevated CVD risk." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Coffee, Caffeine, and Health Outcomes: An Umbrella Review. (Annual review of nutrition 2017) · cited 537x in the literature
"Of the 59 unique outcomes examined in the selected 112 meta-analyses of observational studies, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers; cardiovascular disease and mortality; Parkinson's disease; and type-2 diabetes." (abstract, results, passage verified)
pubmedfull study (doi) - context: Coffee consumption and health: umbrella review of meta-analyses of multiple health outcome… (BMJ (Clinical research ed.) 2017) · cited 822x in the literature
"There was evidence of a non-linear association between consumption and some outcomes, with summary estimates indicating largest relative risk reduction at intakes of three to four cups a day versus none, including all cause mortality (relative risk 0.83 (95% confidence interval 0.79 to 0.88), cardiovascular mortality (0.81, 0.72 to 0.90), and cardiovascular disease (0.85, 0.80 to 0.90)." (abstract, results, passage verified)
pubmedfull study (doi)